Overview
OcuTerra Therapeutics, Inc., formerly known as SciFluor Life Sciences, Inc., is an ophthalmology drug development company, based in Boston, MA, focused on treating eye diseases with innovative new products. The Company is advancing OTT166 into mid-stage clinical development for the treatment of diabetic retinopathy, a chronic, progressive disease affecting the back of the eye that affects about 30% of diabetics and is becoming increasingly prevalent with the global epidemic of diabetes.